New Cousteau-Linked...
Health Care: Drugs
Anika Therapeutics Inc. (ANIK: NASDAQ)
$13.01 -0.59 | -4.34%
06/01/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 8.47M | 4.32M | 3.69M | 3.63M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -3.00M | -3.72M | -1.70M | 377.55K |
| (Increase) Decrease in Inventories | 224.71K | -1.22M | -1.87M | -1.27M |
| (Increase) Decrease In Other Current Assets | 179.94K | 0.00 | 93.56K | 0.00 |
| (Decrease) Increase In Payables | -6.59M | 5.78M | 141.08K | -129.66K |
| (Decrease) Increase In Other Current Liabilities | 1.28M | -2.19M | -962.52K | -678.88K |
| (Increase) Decrease In Other Working Capital | -568.00 | -2.88M | 168.69K | -2.48M |
| Other Non-Cash Items | 2.68M | 2.04M | 1.28M | 1.27M |
| Net Cash From Continuing Operations | 10.17M | 7.85M | 3.09M | 3.41M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 10.17M | 7.85M | 3.09M | 3.41M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 3.50M |
| Purchases of Property, Plant & Equipment | -1.40M | -2.78M | -3.96M | -16.25M |
| Acquisitions | 0.00 | 105.30K | -16.26M | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | -58.06K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -1.40M | -2.68M | -20.22M | -12.80M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 16.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 160.47K | 197.25K | 3.15K | 516.98K |
| Repayment of Long-Term Debt | -1.60M | -1.60M | -1.67M | -87.72K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 274.19K | 65.43K | 27.35K | 258.15K |
| Net Cash From Financing Activities | -1.17M | -1.34M | -1.64M | 16.69M |
| Effect of Exchange Rate Changes | -32.16K | -61.52K | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 7.58M | 3.77M | -18.77M | 7.29M |
Portfolios with ANIK
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserTrade Growth
- Userbfab Portfolio 1
- Usersome mad buggers wall
- Usermjaquillard Portfolio 1
- UserJenaLoren Stocks
- Usermagic formula cws
- UserLittle Nicky's Pop
Latest ANIK Headlines from TheStreet
- Anika Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.04.12 | 12:05 pm
- 8 Stocks Rising on Unusual Volume 04.09.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 04.02.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 03.21.12 | 02:03 pm
- Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.01.12 | 06:03 pm
- Anika Therapeutics Inc. Stock Upgraded (ANIK) 11.15.11 | 06:11 am
- Anika Therapeutics' CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 02:11 pm
- Anika Stock Soars (ANIK) 11.03.11 | 09:11 am
- Anika Therapeutics CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.05.11 | 02:08 pm
- Anika Therapeutics Inc. Stock Downgraded (ANIK) 05.09.11 | 08:05 am
Press Releases for ANIK
- Anika Therapeutics Announces Date Of First-Quarter 2012 Financial Results Conference Call - Business Wire 04.26.12 | 08:04 am
- Anika Therapeutics Reports 25% Increase In Fourth-Quarter Revenue - Business Wire 02.29.12 | 05:02 pm
- Anika Therapeutics Announces Date Of Fourth-Quarter And Year-End 2011 Financial Results Conference Call - Business Wire 02.23.12 | 09:02 am
- Anika Therapeutics To Present At The Canaccord Genuity Musculoskeletal Conference On February 7 - Business Wire 02.02.12 | 01:02 pm
- Anika Therapeutics To Present At The Eighth Annual Noble Financial Equity Conference On January 17 - Business Wire 01.10.12 | 10:01 am
- Anika Therapeutics Announces U.S. MONOVISC® License And Supply Agreement With DePuy Mitek, Inc. - Business Wire 12.21.11 | 03:12 pm
- Anika Therapeutics To Present At The LD Micro Conference On December 8 - Business Wire 11.30.11 | 11:11 am
- Anika Therapeutics To Present At The Security Research Associates 7th Annual Fall Growth Stock Conference On November 15 - PR Newswire 11.15.11 | 08:11 am
- Anika Therapeutics To Present At The Security Research Associates 7th Annual Fall Growth Stock Conference On November 15 - PR Newswire 11.10.11 | 08:11 am
- Anika Therapeutics Reports 33% Revenue Growth In Third Quarter 2011 - Business Wire 11.02.11 | 04:11 pm
Partner Headlines for ANIK
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.30.12 | 09:05 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 05.25.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.23.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.17.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.10.12 | 09:05 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.08.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 04.25.12 | 09:04 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 04.20.12 | 09:04 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 04.16.12 | 09:04 am
- Two Stocks Crossing Over Their 50 Day Moving Averages (ANIK, EKB) - Benzinga 11.30.10 | 01:11 pm
